Two new research institutes at Monash University

The Academic Board at Monash University has recently approved two new research institutes.  The Monash Biomedicine Discovery Institute (BDI) and the Monash Institute for Cognitive and Clinical Neurosciences (ICCN) will facilitate collaboration of researchers and clinical partners to translate scientific breakthroughs into usable treatments.

The two new institutes, together with the existing Australian Regenerative Medicine Institute (ARMI) will form a unique research precinct within the Faculty of Medicine, Nursing and Health Sciences at Monash.  The research precinct will have over 150 research groups, 700 staff and nearly 400 PhD students, working on projects that could help treat a multitude of diseases and conditions.

Monash Biomedicine Discovery Institute (BDI): Discovery Programs in immunity and infection, cancer, development and stem cells, cardiovascular disease, metabolic disease and obesity, and neuroscience.

Monash Institute for Cognitive and Clinical Neurosciences (ICCN): Discovery and clinical translation programs in addiction science, attention and memory, and sleep.

The institutes will be officially launched later in the year, but we hope to start seeing the results of some of their valuable research being announced soon after.

You can find out more about studying at Monash University on their profile.  If you are interested in studying or researching in Health Sciences and Medicine, contact Study Options for more information.